It's shaping up to be another day of losses on the U.S. exchanges, thanks to disappointing retail sales and ugly earnings from a blue-chip tech titan. Among the equities in focus are retailer J C Penney Company Inc (NYSE:JCP), pharmaceutical interest Mylan NV (NASDAQ:MYL), and genetic analysis issue Illumina, Inc. (NASDAQ:ILMN).
ILMN is up 5.5% this morning, last seen trading at $163.90, on the news that the stock will be listed on the S&P 500 Index (SPX) as of next Wednesday's close, replacing Sigma-Aldrich Corporation (NASDAQ:SIAL). Illumina, Inc. shares fell to an annual low of $130 in early October, after the company issued lackluster guidance, but have rebounded 26.1% since then. Option buyers have turned bullish over the last several weeks, as ILMN's 10-day call/put volume ratio on the International Securities Exchange (ISE), Chicago Board Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX) sits at 3.62 -- higher than 94% of readings from the past year.
Minimize Risk While Maximizing Profits
There is no options strategy like this one, which consistently minimizes risk while maintaining maximum profits. Perfect for traders looking for ways to control risk, reduce losses, and increase the likelihood of success when trading calls and puts. The Schaeffer’s team has over 41 years of options trading success targeting +100% gains on every trade. Rest assured your losses are effectively limited to your initial cost at the time of making your move! Don't waste another second... join us right now before the next trade is released!
